Product Code: PM5035
The global subcutaneous drug delivery devices market size is expected to reach USD 53.50 billion by 2032, according to a new study by Polaris Market Research. The report "Subcutaneous Drug Delivery Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type (Auto-Injectors, Pre-filled Syringes, Pen Injectors, Wearable Injectors, and Needle Free Injectors), By Usability, By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The subcutaneous drug delivery devices market encompasses products designed for the administration of medication under the skin, such as insulin pens, auto-injectors, and infusion pumps. These devices facilitate controlled, patient-friendly drug delivery for chronic conditions, improving adherence and therapeutic outcomes.
The global subcutaneous drug delivery devices market is experiencing robust growth driven by several key factors. The increasing prevalence of chronic diseases such as diabetes and rheumatoid arthritis, which require frequent medication administration, is significantly boosting demand for subcutaneous delivery solutions. Additionally, technological advancements in device design and the development of smart devices with integrated monitoring systems are enhancing patient compliance and convenience.
The emerging trend toward personalized medicine, which necessitates precise and adjustable dosing regimens, is also contributing to the market expansion. Moreover, the growing emphasis on home healthcare and self-administration of medications is further fueling the adoption of subcutaneous drug delivery devices. These factors, coupled with innovations in device technology, are expected to continue shaping the market's trajectory.
Subcutaneous Drug Delivery Devices Market Report Highlights
Based on product type, the auto-injectors segment dominates the subcutaneous drug delivery devices market, driven by their ease of use, convenience, and the growing prevalence of chronic diseases that require frequent self-administration.
By usability, the disposable devices segment holds the dominant position in the market due to their convenience, ease of use, and reduced risk of infection, which appeals to patients and healthcare providers.
In terms of distribution channel, the hospital pharmacies segment remains the dominating segment due to their established infrastructure and the high volume of chronic disease patients requiring regular medication.
North America dominates the market, whereas Asia Pacific is expected to witness the highest growth rate during the forecast period.
Key players in the subcutaneous drug delivery devices market include AbbVie, Medtronic, Novo Nordisk, Eli Lilly, Becton, Dickinson and Company (BD), Johnson & Johnson, Insulet Corporation, Ypsomed, Sanofi, Roche, Bayer, Terumo Corporation, Pfizer, 3M, and Dexcom.
Polaris Market Research has segmented the subcutaneous drug delivery devices market report on the basis of product type, usability, distribution channel, and region.
Subcutaneous Drug Delivery Devices - Product Type Outlook (Revenue - USD Billion, 2019-2032)
- Auto-Injectors
- Pre-filled Syringes
- Pen Injectors
- Wearable Injectors
- Needle Free Injectors
Subcutaneous Drug Delivery Devices - Usability Outlook (Revenue - USD Billion, 2019-2032)
- Disposable Devices
- Reusable Devices
Subcutaneous Drug Delivery Devices - Distribution Channel Outlook (Revenue - USD Billion, 2019-2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Subcutaneous Drug Delivery Devices - Regional Outlook (Revenue - USD Billion, 2019-2032)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Subcutaneous Drug Delivery Devices Market Insights
- 4.1. Subcutaneous Drug Delivery Devices Market - Market Snapshot
- 4.2. Subcutaneous Drug Delivery Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise of Smart Devices with Integrated Monitoring Are Driving Market Growth
- 4.2.1.2. Growing Demand for Home Healthcare Solutions is Propelling Market Size
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs of Advanced Devices
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Subcutaneous Drug Delivery Devices Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Subcutaneous Drug Delivery Devices Market, by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 5.3. Auto-Injectors
- 5.3.1. Global Subcutaneous Drug Delivery Devices Market, by Auto-Injectors, by Region, 2019-2032 (USD billion)
- 5.4. Pre-filled Syringes
- 5.4.1. Global Subcutaneous Drug Delivery Devices Market, by Pre-filled Syringes, by Region, 2019-2032 (USD billion)
- 5.5. Pen Injectors
- 5.5.1. Global Subcutaneous Drug Delivery Devices Market, by Pen Injectors, by Region, 2019-2032 (USD billion)
- 5.6. Wearable Injectors
- 5.6.1. Global Subcutaneous Drug Delivery Devices Market, by Wearable Injectors, by Region, 2019-2032 (USD billion)
- 5.7. Needle Free Injectors
- 5.7.1. Global Subcutaneous Drug Delivery Devices Market, by Needle Free Injectors, by Region, 2019-2032 (USD billion)
6. Global Subcutaneous Drug Delivery Devices Market, by Usability
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 6.3. Disposable Devices
- 6.3.1. Global Subcutaneous Drug Delivery Devices Market, by Disposable Devices, by Region, 2019-2032 (USD billion)
- 6.4. Reusable Devices
- 6.4.1. Global Subcutaneous Drug Delivery Devices Market, by Reusable Devices, by Region, 2019-2032 (USD billion)
7. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 7.3. Hospital Pharmacies
- 7.3.1. Global Subcutaneous Drug Delivery Devices Market, by Hospital Pharmacies, by Region, 2019-2032 (USD billion)
- 7.4. Retail Pharmacies
- 7.4.1. Global Subcutaneous Drug Delivery Devices Market, by Retail Pharmacies, by Region, 2019-2032 (USD billion)
- 7.5. Online Pharmacies
- 7.5.1. Global Subcutaneous Drug Delivery Devices Market, by Online Pharmacies, by Region, 2019-2032 (USD billion)
8. Global Subcutaneous Drug Delivery Devices Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Subcutaneous Drug Delivery Devices Market Assessment, By Geography, 2019-2032 (USD billion)
- 8.3. Subcutaneous Drug Delivery Devices Market - North America
- 8.3.1. North America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.3.2. North America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.3.3. North America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.3.4. Subcutaneous Drug Delivery Devices Market - U.S.
- 8.3.4.1. U.S.: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.3.4.2. U.S.: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.3.4.3. U.S.: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.3.5. Subcutaneous Drug Delivery Devices Market - Canada
- 8.3.5.1. Canada: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.3.5.2. Canada: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.3.5.3. Canada: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4. Subcutaneous Drug Delivery Devices Market - Europe
- 8.4.1. Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.2. Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.3. Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.4. Subcutaneous Drug Delivery Devices Market - UK
- 8.4.4.1. UK: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.4.2. UK: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.4.3. UK: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.5. Subcutaneous Drug Delivery Devices Market - France
- 8.4.5.1. France: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.5.2. France: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.5.3. France: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.6. Subcutaneous Drug Delivery Devices Market - Germany
- 8.4.6.1. Germany: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.6.2. Germany: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.6.3. Germany: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.7. Subcutaneous Drug Delivery Devices Market - Italy
- 8.4.7.1. Italy: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.7.2. Italy: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.7.3. Italy: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.8. Subcutaneous Drug Delivery Devices Market - Spain
- 8.4.8.1. Spain: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.8.2. Spain: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.8.3. Spain: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.9. Subcutaneous Drug Delivery Devices Market - Netherlands
- 8.4.9.1. Netherlands: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.9.2. Netherlands: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.9.3. Netherlands: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.10. Subcutaneous Drug Delivery Devices Market - Russia
- 8.4.10.1. Russia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.10.2. Russia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.10.3. Russia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.4.11. Subcutaneous Drug Delivery Devices Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.4.11.2. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.4.11.3. Rest of Europe: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5. Subcutaneous Drug Delivery Devices Market - Asia Pacific
- 8.5.1. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.2. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.3. Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.4. Subcutaneous Drug Delivery Devices Market - China
- 8.5.4.1. China: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.4.2. China: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.4.3. China: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.5. Subcutaneous Drug Delivery Devices Market - India
- 8.5.5.1. India: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.5.2. India: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.5.3. India: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.6. Subcutaneous Drug Delivery Devices Market - Malaysia
- 8.5.6.1. Malaysia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.6.2. Malaysia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.6.3. Malaysia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.7. Subcutaneous Drug Delivery Devices Market - Japan
- 8.5.7.1. Japan: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.7.2. Japan: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.7.3. Japan: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.8. Subcutaneous Drug Delivery Devices Market - Indonesia
- 8.5.8.1. Indonesia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.8.2. Indonesia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.8.3. Indonesia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.9. Subcutaneous Drug Delivery Devices Market - South Korea
- 8.5.9.1. South Korea: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.9.2. South Korea: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.9.3. South Korea: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.10. Subcutaneous Drug Delivery Devices Market - Australia
- 8.5.10.1. Australia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.10.2. Australia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.10.3. Australia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.5.11. Subcutaneous Drug Delivery Devices Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.5.11.2. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.5.11.3. Rest of Asia Pacific: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.6. Subcutaneous Drug Delivery Devices Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.6.2. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.6.3. Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.6.4. Subcutaneous Drug Delivery Devices Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.6.4.2. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.6.4.3. Saudi Arabia: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.6.5. Subcutaneous Drug Delivery Devices Market - UAE
- 8.6.5.1. UAE: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.6.5.2. UAE: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.6.5.3. UAE: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.6.6. Subcutaneous Drug Delivery Devices Market - Israel
- 8.6.6.1. Israel: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.6.6.2. Israel: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.6.6.3. Israel: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.6.7. Subcutaneous Drug Delivery Devices Market - South Africa
- 8.6.7.1. South Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.6.7.2. South Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.6.7.3. South Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.6.8. Subcutaneous Drug Delivery Devices Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.6.8.2. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.6.8.3. Rest of Middle East & Africa: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.7. Subcutaneous Drug Delivery Devices Market - Latin America
- 8.7.1. Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.7.2. Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.7.3. Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.7.4. Subcutaneous Drug Delivery Devices Market - Mexico
- 8.7.4.1. Mexico: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.7.4.2. Mexico: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.7.4.3. Mexico: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.7.5. Subcutaneous Drug Delivery Devices Market - Brazil
- 8.7.5.1. Brazil: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.7.5.2. Brazil: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.7.5.3. Brazil: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.7.6. Subcutaneous Drug Delivery Devices Market - Argentina
- 8.7.6.1. Argentina: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.7.6.2. Argentina: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.7.6.3. Argentina: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
- 8.7.7. Subcutaneous Drug Delivery Devices Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Product Type, 2019-2032 (USD billion)
- 8.7.7.2. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Usability, 2019-2032 (USD billion)
- 8.7.7.3. Rest of Latin America: Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2019-2032 (USD billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AbbVie
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Medtronic
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Novo Nordisk
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Eli Lilly
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Becton, Dickinson and Company (BD)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Johnson & Johnson
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Insulet Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Ypsomed
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Sanofi
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Roche
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Bayer
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Terumo Corporation
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Pfizer
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. 3M
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Dexcom
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development